Evidence-informed Choice for Women Participating in Mammography Screening
NCT ID: NCT01335906
Last Updated: 2014-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
332 participants
INTERVENTIONAL
2011-01-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Information About the Benefits and Harms of Mammography on Women's Decision Making
NCT03046004
Trial of a Mammography Decision Aid for Women Aged 75 and Older
NCT02198690
Communicating Objective Risk for Personalized Decision Making About Mammography
NCT01686360
Promoting Informed Choice for Breast Cancer Screening: A Longitudinal Study
NCT05838417
The Effect of a Patient Decision Aids for Breast Cancer Screening
NCT04948983
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Evidence-based informed consent
Information
The experimental information consists of receiving verbal and written evidence-based information about the benefits and risks of mammography screening program. The standard information consists of receiving the information that public institutions provide to the women invited to the screening program.
Usual information
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Information
The experimental information consists of receiving verbal and written evidence-based information about the benefits and risks of mammography screening program. The standard information consists of receiving the information that public institutions provide to the women invited to the screening program.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women aged between 45 and 69 years
* Women invited to breast screening program and who attend it
* Qualified women to give informed consent to participate in the study
Exclusion Criteria
45 Years
69 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Andaluz Health Service
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
José Manuel Baena Cañada
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
José M Baena-Cañada, MD, PhD
Role: STUDY_CHAIR
Oncology Unit, University Hospital Puerta del Mar, Cádiz
Petra Rosado, MD
Role: STUDY_DIRECTOR
Oncology Unit, University Hospital Puerta del Mar, Cádiz
Inmaculada Expósito, Chemistry
Role: PRINCIPAL_INVESTIGATOR
Oncology Unit, University Hospital Puerta del Mar, Cádiz
María del Carmen Díaz, Chemistry
Role: PRINCIPAL_INVESTIGATOR
Oncology Unit, University Hospital Puerta del Mar, Cádiz
Juan Nieto, MD
Role: PRINCIPAL_INVESTIGATOR
Health District Bay of Cádiz-La Janda
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oncology Unit, Puerta del Mar University Hospital
Cadiz, Andalusia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI-0315-2010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.